Panda Sangita, Subudhi Enketeswara, Routray Sweta Padma, Nair Sujit
Centre for Biotechnology, Siksha 'O' Anusandhan University (Deemed to be University), Bhubaneswar, India.
29396 University of Mumbai , Santa Cruz, Mumbai, India.
Drug Metab Pers Ther. 2025 Apr 23;40(2):107-120. doi: 10.1515/dmpt-2024-0099. eCollection 2025 Jun 1.
Hepatocellular carcinoma (HCC) is a common type of liver cancer that progresses quickly and has limited treatment options. Nutraceutical anacardic acid (AA), a bioactive compound derived from cashew nut shell, has emerged as a potential candidate for HCC treatment owing to its reported anti-inflammatory, anticancer and diverse pharmacological properties. In the present study, we investigate the potential of AA as an HCC inhibitor using molecular docking, gene ontology, and network pharmacology.
The pharmacokinetic and physicochemical properties of AA were assessed using Swiss ADME. SuperPred, Similarity Ensemble Approach, ChEMBL and Swiss Target Prediction online tools were used for determining molecular targets of AA. In addition, GeneCards, NCBI, DisGeNET and UniProt ID were used to search the targets of HCC and the top 25 hub genes were determined using Cytohubba plugin. A protein protein interaction (PPI) network was constructed through the STRING database. Gene Ontology (GO) biological process and Kyoto Encyclopaedia of Genes and Genes (KEGG) pathway enrichment analysis were performed through FunRich and ShinyGO 0.77. Moreover, molecular docking studies were performed on NF-κB and GSK-3β. The expression levels of the hub genes were also validated by western blotting.
Comprehensive data analysis identified 375 targets for AA and 11,333 for HCC, with 264 targets in common. Network analysis determined 25 key HCC targets, including caspase-3, and NF-κB. Gene ontology and topology analysis highlighted essential pathways implicated in HCC progression such as the renin-angiotensin system, VEGF signalling, and apoptosis. Molecular docking analysis revealed strong binding affinity of HCC proteins with NF-κB and GSK-3β. Upregulation of p-NRF2 and p-GSK-3β, and downregulation of p-NF-κB and caspase-1 expression were validated using western blotting.
Taken together, our study highlights the potential of AA as a promising chemopreventive agent for HCC because of its significant modulatory effects on important regulatory proteins linked to cell division, inflammation, apoptosis, and antioxidant response.
肝细胞癌(HCC)是一种常见的肝癌类型,进展迅速且治疗选择有限。营养保健品漆树酸(AA)是一种从腰果壳中提取的生物活性化合物,因其具有抗炎、抗癌和多种药理特性,已成为肝癌治疗的潜在候选药物。在本研究中,我们使用分子对接、基因本体论和网络药理学来研究AA作为肝癌抑制剂的潜力。
使用瑞士ADME评估AA的药代动力学和理化性质。使用SuperPred、相似性集成方法、ChEMBL和瑞士靶点预测在线工具来确定AA的分子靶点。此外,使用GeneCards、NCBI、DisGeNET和UniProt ID搜索肝癌的靶点,并使用Cytohubba插件确定前25个枢纽基因。通过STRING数据库构建蛋白质-蛋白质相互作用(PPI)网络。通过FunRich和ShinyGO 0.77进行基因本体论(GO)生物学过程和京都基因与基因组百科全书(KEGG)通路富集分析。此外,对NF-κB和GSK-3β进行分子对接研究。还通过蛋白质印迹法验证了枢纽基因的表达水平。
综合数据分析确定AA有375个靶点,肝癌有11333个靶点,其中有264个共同靶点。网络分析确定了25个关键的肝癌靶点,包括半胱天冬酶-3和NF-κB。基因本体论和拓扑分析突出了与肝癌进展相关的重要通路,如肾素-血管紧张素系统、VEGF信号传导和细胞凋亡。分子对接分析显示肝癌蛋白与NF-κB和GSK-3β具有很强的结合亲和力。使用蛋白质印迹法验证了p-NRF2和p-GSK-3β的上调以及p-NF-κB和半胱天冬酶-1表达的下调。
综上所述,我们的研究突出了AA作为一种有前景的肝癌化学预防剂的潜力,因为它对与细胞分裂、炎症、细胞凋亡和抗氧化反应相关的重要调节蛋白具有显著的调节作用。